Novel celecoxib-loaded chitosan-fucoidan nanoparticles as potential immunotherapy for oral squamous cell carcinoma: Mechanistic insights-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel celecoxib-loaded chitosan-fucoidan nanoparticles as potential immunotherapy for oral squamous cell carcinoma: Mechanistic insights

Published:2023-03 Issue: Volume:81 Page:104228
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Mabrouk Aya A.,El-Mezayen Nesrine S.,Awaad Ashraf K.,Tadros Mina I.^ORCID,El-Gazayerly Omaima N.^ORCID,El-Refaie Wessam M.^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference98 articles.

1. Progress in targeted therapeutic drugs for oral squamous cell carcinoma;Liu;Surg Oncol,2019

2. Tumor microenvironment complexity and therapeutic implications at a glance;Baghban;Cell Commun. Signal.,2020

3. Brown seaweed fucoidan: biological activity and apoptosis, growth signaling mechanism in cancer;Senthilkumar;Int. J. Biol. Macromol.,2013

4. Doxorubicin-loaded fucoidan capped gold nanoparticles for drug delivery and photoacoustic imaging;Manivasagan;Int. J. Biol. Macromol.,2016

5. Fucoidan–fucoxanthin ameliorated cardiac function via IrS1/Grb2/SOS1, GSK3β/CREB pathways and metabolic pathways in senescent mice;Chang;Mar. Drugs,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Valsartan as a prophylactic treatment against breast cancer development and niche activation: What molecular sequels follow chronic AT-1R blockade?;Life Sciences;2024-09

2. Codelivery of ivermectin and methyl dihydrojasmonate in nanostructured lipid carrier for synergistic antileukemia therapy;International Journal of Pharmaceutics;2024-05

3. Prodigiosin/celecoxib-loaded into zein/sodium caseinate nanoparticles as a potential therapy for triple negative breast cancer;Scientific Reports;2024-01-02

4. Targeting the oral tumor microenvironment by nanoparticles: A review of progresses;Journal of Drug Delivery Science and Technology;2024-01

5. Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles;Environmental Research;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3